139 related articles for article (PubMed ID: 7613632)
21. Cholinergic stimulation of substantia nigra: abolition of carbachol-induced eating by unilateral 6-hydroxydopamine lesion of nigrostriatal dopamine neurones.
Parker GC; Rugg EL; Winn P
Exp Brain Res; 1991; 87(3):597-603. PubMed ID: 1723691
[TBL] [Abstract][Full Text] [Related]
22. Increased melatonin may play dual roles in the striata of a 6-hydroxydopamine model of Parkinson's disease.
Lin L; Meng T; Liu T; Zheng Z
Life Sci; 2013 Mar; 92(4-5):311-6. PubMed ID: 23333823
[TBL] [Abstract][Full Text] [Related]
23. A potential target for the treatment of Parkinson's disease: effect of lateral habenula lesions.
Han B; Jin HJ; Song MY; Wang T; Zhao H
Parkinsonism Relat Disord; 2014 Nov; 20(11):1191-5. PubMed ID: 25219971
[TBL] [Abstract][Full Text] [Related]
24. A continuous striatal infusion of 6-hydroxydopamine produces a terminal axotomy and delayed behavioral effects.
Jones BE; Boylan CB; Fritsche M; Juhasz M; Jackson C; Wiegand SJ; Hyman C; Lindsay RM; Altar CA
Brain Res; 1996 Feb; 709(2):275-84. PubMed ID: 8833764
[TBL] [Abstract][Full Text] [Related]
25. Neuroleptic-like disruption of the conditioned avoidance response requires destruction of both the mesolimbic and nigrostriatal dopamine systems.
Koob GF; Simon H; Herman JP; Le Moal M
Brain Res; 1984 Jun; 303(2):319-29. PubMed ID: 6430466
[TBL] [Abstract][Full Text] [Related]
26. Depletion of dopamine in the caudate nucleus but not in nucleus accumbens impairs reaction-time performance in rats.
Amalric M; Koob GF
J Neurosci; 1987 Jul; 7(7):2129-34. PubMed ID: 3112323
[TBL] [Abstract][Full Text] [Related]
27. Biotransformation of L-dopa in striatum and substantia nigra of rats with a unilateral, nigrostriatal lesion: a microdialysis study.
Sarre S; Herregodts P; Deleu D; Devrieze A; De Klippel N; Ebinger G; Michotte Y
Naunyn Schmiedebergs Arch Pharmacol; 1992 Sep; 346(3):277-85. PubMed ID: 1407014
[TBL] [Abstract][Full Text] [Related]
28. The antioxidant drink effective microorganism-X (EM-X) pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson's disease.
Datla KP; Bennett RD; Zbarsky V; Ke B; Liang YF; Higa T; Bahorun T; Aruoma OI; Dexter DT
J Pharm Pharmacol; 2004 May; 56(5):649-54. PubMed ID: 15142343
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of brain-derived neurotrophic factor and neurotrophin-3 on neurochemical and behavioral deficits associated with partial nigrostriatal dopamine lesions.
Altar CA; Boylan CB; Fritsche M; Jones BE; Jackson C; Wiegand SJ; Lindsay RM; Hyman C
J Neurochem; 1994 Sep; 63(3):1021-32. PubMed ID: 7519657
[TBL] [Abstract][Full Text] [Related]
30. Time-dependent striatal dopamine depletion after injection of 6-hydroxydopamine in the rat. Comparison of single bilateral and double bilateral lesions.
Ben V; Blin O; Bruguerolle B
J Pharm Pharmacol; 1999 Dec; 51(12):1405-8. PubMed ID: 10678495
[TBL] [Abstract][Full Text] [Related]
31. Tyrosine administration increases striatal dopamine release in rats with partial nigrostriatal lesions.
Melamed E; Hefti F; Wurtman RJ
Proc Natl Acad Sci U S A; 1980 Jul; 77(7):4305-9. PubMed ID: 6254020
[TBL] [Abstract][Full Text] [Related]
32. Early and widespread normalization of dopamine-neuropeptide Y interactions in the rat striatum after transplantation of fetal mesencephalon cells.
Moukhles H; Nieoullon A; Daszuta A
Neuroscience; 1992; 47(4):781-92. PubMed ID: 1349734
[TBL] [Abstract][Full Text] [Related]
33. Neuroprotective and neurotrophic effect of apomorphine in the striatal 6-OHDA-lesion rat model of Parkinson's disease.
Yuan H; Sarre S; Ebinger G; Michotte Y
Brain Res; 2004 Nov; 1026(1):95-107. PubMed ID: 15476701
[TBL] [Abstract][Full Text] [Related]
34. Intrastriatal quinolinic acid injections protect against 6-hydroxydopamine-induced lesions of the dopaminergic nigrostriatal system.
Venero JL; Romero-Ramos M; Revuelta M; Machado A; Cano J
Brain Res; 1995 Feb; 672(1-2):153-8. PubMed ID: 7749737
[TBL] [Abstract][Full Text] [Related]
35. Morphological and biochemical adaptations to unilateral dopamine denervation of the neostriatum in newborn rats.
Penit-Soria J; Durand C; Herve D; Besson MJ
Neuroscience; 1997 Apr; 77(3):753-66. PubMed ID: 9070750
[TBL] [Abstract][Full Text] [Related]
36. Changes in SK channel expression in the basal ganglia after partial nigrostriatal dopamine lesions in rats: Functional consequences.
Mourre C; Manrique C; Camon J; Aidi-Knani S; Deltheil T; Turle-Lorenzo N; Guiraudie-Capraz G; Amalric M
Neuropharmacology; 2017 Feb; 113(Pt A):519-532. PubMed ID: 27825825
[TBL] [Abstract][Full Text] [Related]
37. Correlation of apomorphine- and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats.
Hudson JL; van Horne CG; Strömberg I; Brock S; Clayton J; Masserano J; Hoffer BJ; Gerhardt GA
Brain Res; 1993 Oct; 626(1-2):167-74. PubMed ID: 8281427
[TBL] [Abstract][Full Text] [Related]
38. Impaired acquisition of skilled behavior in rotarod task by moderate depletion of striatal dopamine in a pre-symptomatic stage model of Parkinson's disease.
Ogura T; Ogata M; Akita H; Jitsuki S; Akiba L; Noda K; Hoka S; Saji M
Neurosci Res; 2005 Mar; 51(3):299-308. PubMed ID: 15710494
[TBL] [Abstract][Full Text] [Related]
39. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
[TBL] [Abstract][Full Text] [Related]
40. Reserpine pretreatment prevents increases in extracellular striatal dopamine following L-DOPA administration in rats with nigrostriatal denervation.
Kannari K; Tanaka H; Maeda T; Tomiyama M; Suda T; Matsunaga M
J Neurochem; 2000 Jan; 74(1):263-9. PubMed ID: 10617128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
